Operating cash-flow margin moved 451 bp lower
Operating cash-flow margin changed -451 basis points from the comparable as-filed period.
19.11%→14.61%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BKE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 990 bp lower
Free-cash-flow margin changed -990 basis points from the comparable as-filed period.
15.18%→5.27%2 prior comparisons
Operating margin moved 98 bp lower
Operating margin changed -98 basis points from the comparable as-filed period.
18.43%→17.45%2 prior comparisons
Current assets decreased 2.2%
Current assets changed -2.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$493.3M→$482.2M4 prior comparisons
Revenue increased 4.6%
Revenue changed +4.6% from the comparable as-filed period.
$305.7M→$319.8M2 prior comparisons
Gross margin moved 42 bp higher
Gross margin changed +42 basis points from the comparable as-filed period.
47.43%→47.85%2 prior comparisons
Inventory increased 13.3%
Inventory changed +13.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$142.5M→$161.4M4 prior comparisons
Total assets increased 6.4%
Total assets changed +6.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.0B→$1.1B4 prior comparisons
Working capital decreased 4.9%
Working capital changed -4.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$263.7M→$250.8M4 prior comparisons
Current ratio decreased 3.1%
Current ratio changed -3.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
2.15→2.084 prior comparisons
Operating cash flow / net income decreased 19.0%
Operating cash flow / net income changed -19.0% from the comparable as-filed period.
1.3→1.052 prior comparisons
Selling, general & administrative increased 9.6%
Selling, general & administrative changed +9.6% from the comparable as-filed period.
$88.7M→$97.2M2 prior comparisons
Shares outstanding increased 0.7%
Shares outstanding changed +0.7% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
51,156,626→51,512,4348 prior comparisons
Operating income decreased 1.0%
Operating income changed -1.0% from the comparable as-filed period.
$56.3M→$55.8M2 prior comparisons
Gross profit increased 5.5%
Gross profit changed +5.5% from the comparable as-filed period.
$145.0M→$153.0M2 prior comparisons
Net income decreased 1.3%
Net income changed -1.3% from the comparable as-filed period.
$45.0M→$44.4M2 prior comparisons
Current liabilities increased 0.8%
Current liabilities changed +0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$229.6M→$231.5M4 prior comparisons
Revenue increased 6.1%
Revenue changed +6.1% from the comparable as-filed period.
$272.1M→$288.7M3 prior comparisons
Selling, general & administrative decreased 11.3%
Selling, general & administrative changed -11.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$83.4M→$74.0M3 prior comparisons
Capex / revenue moved 89 bp higher
Capex / revenue changed +89 basis points from the comparable as-filed period.
4.19%→5.08%2 prior comparisons
Gross margin moved 43 bp lower
Gross margin changed -43 basis points from the comparable as-filed period.
46.66%→46.23%3 prior comparisons
Inventory increased 13.4%
Inventory changed +13.4% from the comparable as-filed period.
$132.4M→$150.2M3 prior comparisons
Gross profit increased 5.1%
Gross profit changed +5.1% from the comparable as-filed period.
$127.0M→$133.5M3 prior comparisons
Cash & equivalents decreased 1.0%
Cash & equivalents changed -1.0% from the comparable as-filed period.
$268.9M→$266.2M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.